Carlos Nueno, President, International of Teladoc Health, Inc. (NYSE:TDOC), filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a subsequent sale of common stock on September 1 and 2, 2026.
Key Highlights
- RSU vesting (9/1/2026): 4,556 restricted stock units converted to common stock on a one-for-one basis from a March 19, 2024 grant.
- Second RSU vesting (9/1/2026): 8,717 restricted stock units converted to common stock on a one-for-one basis from a March 1, 2025 grant.
- Shares sold (9/2/2026): 6,200 shares were sold at $6.301 per share to cover tax withholding obligations related to the RSU vestings.
- Beneficial ownership after transactions: Nueno directly held 64,744 shares of common stock following the reported transactions.
- Remaining RSUs: 9,114 RSUs from the 2024 grant and 52,302 RSUs from the 2025 grant remain outstanding as of the filing date.
RSU Vestings and Tax-Related Sale Detail for Teladoc Health's International President
According to the filing, Carlos Nueno, serving as President, International at Teladoc Health, Inc. (NYSE:TDOC), reported two separate restricted stock unit vestings on September 1, 2026. The first involved 4,556 RSUs originally granted on March 19, 2024, from an award of 54,675 RSUs that vests one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. The second involved 8,717 RSUs originally granted on March 1, 2025, from an award of 104,602 RSUs that vests one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. The filing states that restricted stock units convert to shares of TDOC common stock on a one-for-one basis at a derivative security price of $0.
On September 2, 2026, the filing discloses that Nueno sold 6,200 shares of common stock at a price of $6.301 per share. The filing states these shares were "sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards." Following all three reported transactions, the filing shows Nueno directly held 64,744 shares of Teladoc Health common stock.
The Form 4 was signed by Adam C. Vandervoort as Attorney-in-Fact and filed on September 3, 2026. The filing indicates Nueno's relationship to the issuer as an officer, with no indication of a 10b5-1 plan box being checked for any of the reported transactions.
What Was Disclosed
The filing reported two RSU vestings totaling 13,273 shares acquired on September 1, 2026, and a sale of 6,200 shares at $6.301 on September 2, 2026, solely to satisfy tax withholding obligations, leaving Nueno with 64,744 shares directly held.



Please wait processing your request...